921 related articles for article (PubMed ID: 30581144)
1. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
[TBL] [Abstract][Full Text] [Related]
2. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
3. Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9.
Liu Z; Chen S; Xie W; Song Y; Li J; Lai L; Li Z
Mol Ther; 2022 Jan; 30(1):256-267. PubMed ID: 34174445
[TBL] [Abstract][Full Text] [Related]
4. Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.
Sun W; Yang J; Cheng Z; Amrani N; Liu C; Wang K; Ibraheim R; Edraki A; Huang X; Wang M; Wang J; Liu L; Sheng G; Yang Y; Lou J; Sontheimer EJ; Wang Y
Mol Cell; 2019 Dec; 76(6):938-952.e5. PubMed ID: 31668930
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
6. Compact Cje3Cas9 for Efficient
Chen S; Liu Z; Xie W; Yu H; Lai L; Li Z
CRISPR J; 2022 Jun; 5(3):472-486. PubMed ID: 35686977
[TBL] [Abstract][Full Text] [Related]
7. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
8. A compact Cas9 ortholog from Staphylococcus Auricularis (SauriCas9) expands the DNA targeting scope.
Hu Z; Wang S; Zhang C; Gao N; Li M; Wang D; Wang D; Liu D; Liu H; Ong SG; Wang H; Wang Y
PLoS Biol; 2020 Mar; 18(3):e3000686. PubMed ID: 32226015
[TBL] [Abstract][Full Text] [Related]
9. Target-Specific Precision of CRISPR-Mediated Genome Editing.
Chakrabarti AM; Henser-Brownhill T; Monserrat J; Poetsch AR; Luscombe NM; Scaffidi P
Mol Cell; 2019 Feb; 73(4):699-713.e6. PubMed ID: 30554945
[TBL] [Abstract][Full Text] [Related]
10. A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs.
Maxwell CS; Jacobsen T; Marshall R; Noireaux V; Beisel CL
Methods; 2018 Jul; 143():48-57. PubMed ID: 29486239
[TBL] [Abstract][Full Text] [Related]
11. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
[TBL] [Abstract][Full Text] [Related]
12. The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells.
Lee CM; Cradick TJ; Bao G
Mol Ther; 2016 Mar; 24(3):645-54. PubMed ID: 26782639
[TBL] [Abstract][Full Text] [Related]
13. Programming PAM antennae for efficient CRISPR-Cas9 DNA editing.
Wang F; Hao Y; Li Q; Li J; Zhang H; Zhang X; Wang L; Bustamante C; Fan C
Sci Adv; 2020 May; 6(19):eaay9948. PubMed ID: 32494703
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.
Moreb EA; Hutmacher M; Lynch MD
CRISPR J; 2020 Dec; 3(6):550-561. PubMed ID: 33346713
[TBL] [Abstract][Full Text] [Related]
15. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
Liu L; Yin M; Wang M; Wang Y
Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
[TBL] [Abstract][Full Text] [Related]
16. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
17. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
[TBL] [Abstract][Full Text] [Related]
18. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
[TBL] [Abstract][Full Text] [Related]
19. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
Karvelis T; Gasiunas G; Siksnys V
Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
[TBL] [Abstract][Full Text] [Related]
20. Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM.
Liu Y; Liang F; Dong Z; Li S; Ye J; Qin W
Cells; 2021 Aug; 10(8):. PubMed ID: 34440868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
